Table 4.
Results of the sensitivity analyses
| Total annual cost for 1000 patients with T1DM with MDI | |||
| SMBG | FM system | Absolute difference FM system vs SMBG (percentage variation) | |
| Base case | €4 436 543 | €2 525 779 | €−1 910 764 (−43.1%) |
| SA1 (3.4 severe hypoglycemic episodes/patient-year) | €3 450 749 | €2 117 660 | €−1 333 089 (−38.6%) |
| SA2 (3.2 severe hypoglycemic episodes/patient-year) | €3 319 310 | €2 063 244 | €−1 256 065 (−37.8%) |
| SA3 (1.05 severe hypoglycemia episodes/patient-year) | €1 906 338 | €1 478 274 | €−428 064 (−22.5%) |
| SA4 (0.9 severe hypoglycemia episodes/patient-year) | €1 807 759 | €1 437 462 | €−370 296 (−20.5%) |
| SA5 (including severe and non-severe hypoglycemia) | €4 934 038 | €2 869 261 | €−2 064 777 (−41.85%) |
| SA6 (6 strips and lancets a day for SMBG) | €4 031 115 | €2 525 779 | €−1 505 336 (−37.3%) |
| SA7 (9 strips and 4.5 lancets a day for SMBG) | €4 287 137 | €2 525 779 | €−1 761 358 (−41.1%) |
| SA8 (6 strips and 3 lancets a day for SMBG) | €3 931 512 | €2 525 779 | €−1 405 733 (−35.8%) |
| SA9 (no cost associated with strips and lancets) | €3 220 260 | €2 458 208 | €−762 053 (−23.7%) |
FM, flash monitoring; MDI, multiple dose insulin; SA, sensitivity analysis; SMBG, self-monitoring of capillary glucose; T1DM, type 1 diabetes mellitus.